Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
175M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+10.2M
-
Total reported value, excl. options
-
$171M
-
Value change
-
+$158M
-
Number of buys
-
21
-
Price
-
$15.87
Significant Holders of Immunovant, Inc. - COMMON STOCK (IMVT) as of Q4 2019
23 filings reported holding IMVT - Immunovant, Inc. - COMMON STOCK as of Q4 2019.
Immunovant, Inc. - COMMON STOCK (IMVT) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 175M outstanding shares and own 6.29% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.43M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.02M shares), BVF INC/IL (1M shares), Ghost Tree Capital, LLC (800K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (622K shares), BlackRock Inc. (600K shares), Ikarian Capital, LLC (504K shares), Athanor Capital, LP (500K shares), Polar Capital LLP (394K shares), and Woodline Partners LP (273K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.